These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31522630)

  • 1. Interventions to Improve Metabolic Risk Screening Among Adult Patients Taking Antipsychotic Medication: A Systematic Review.
    Melamed OC; Wong EN; LaChance LR; Kanji S; Taylor VH
    Psychiatr Serv; 2019 Dec; 70(12):1138-1156. PubMed ID: 31522630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.
    Mitchell AJ; Delaffon V; Vancampfort D; Correll CU; De Hert M
    Psychol Med; 2012 Jan; 42(1):125-47. PubMed ID: 21846426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions to Improve Metabolic Risk Screening Among Children and Adolescents on Antipsychotic Medication: A Systematic Review.
    Melamed OC; LaChance LR; O'Neill BG; Rodak T; Taylor VH
    J Child Adolesc Psychopharmacol; 2021 Feb; 31(1):63-72. PubMed ID: 33512274
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of institutional quality improvement initiatives on metabolic monitoring in mental disorder in patients treated with antipsychotics: A meta-analysis of intervention studies.
    Shin S; Moon S; Wang J; Choi YJ
    J Glob Health; 2024 May; 14():04074. PubMed ID: 38783701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
    Connolly JG; Toomey TJ; Schneeweiss MC
    Psychiatr Serv; 2015 Jun; 66(6):604-9. PubMed ID: 25726977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a computerized best practice alert system in an outpatient setting on metabolic monitoring in patients on second-generation antipsychotics.
    Cohen S; Bostwick JR; Marshall VD; Kruse K; Dalack GW; Patel P
    J Clin Pharm Ther; 2020 Dec; 45(6):1398-1404. PubMed ID: 32767599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General practice pharmacist-led antipsychotic physical health monitoring: a prospective intervention scoping study.
    Johnson CF; Ingram F; Thomson F; Srireddy P; Jani BD; Greenlaw N
    Fam Pract; 2024 Feb; 41(1):41-49. PubMed ID: 38180874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation.
    De Hert M; Vancampfort D; Correll CU; Mercken V; Peuskens J; Sweers K; van Winkel R; Mitchell AJ
    Br J Psychiatry; 2011 Aug; 199(2):99-105. PubMed ID: 21804146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for the metabolic syndrome in Australia: a national survey of psychiatrists' attitudes and reported practice in patients prescribed antipsychotic drugs.
    Laugharne J; Waterreus AJ; Castle DJ; Dragovic M
    Australas Psychiatry; 2016 Feb; 24(1):62-6. PubMed ID: 26635377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic grand rounds: economic costs of failure to monitor adverse effects of second-generation antipsychotics: an underestimated factor.
    Jerrell JM; McIntyre RS; Black GB
    Psychiatr Serv; 2012 Mar; 63(3):202-4. PubMed ID: 22388526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication.
    Keenan R; Chepulis L; Ly J; Carter S; Lao C; Asim M; Bhat A; Deo S; Lim KP; Mohammed R; Scarlet S; Lawrenson R
    J Prim Health Care; 2020 Mar; 12(1):29-34. PubMed ID: 32223847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Screening among Antipsychotic-Treated Adults with Severe Mental Illness in an Integrated Delivery System: A Retrospective Cohort Study.
    Mangurian C; Schillinger D; Newcomer JW; Vittinghoff E; Essock S; Zhu Z; Dyer W; Schmittdiel J
    J Gen Intern Med; 2018 Jan; 33(1):79-86. PubMed ID: 29090381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based intervention.
    Lee J; Dalack GW; Casher MI; Eappen SA; Bostwick JR
    J Clin Pharm Ther; 2016 Apr; 41(2):209-13. PubMed ID: 26919449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of treatment guidelines for specialist mental health care.
    Barbui C; Girlanda F; Ay E; Cipriani A; Becker T; Koesters M
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009780. PubMed ID: 24443146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of treatment guidelines for specialist mental health care.
    Bighelli I; Ostuzzi G; Girlanda F; Cipriani A; Becker T; Koesters M; Barbui C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD009780. PubMed ID: 27977851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.